跳至主要内容
临床试验/NCT06994949
NCT06994949招募中1 期

Assessing CSF Flow Dynamics in Pediatric Hemorrhagic Hydrocephalus

Eva Sevick1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2025年1月14日最近更新:
干预措施
相关药物

试验速览

阶段
1 期
状态
招募中
发起方
入组人数
20
试验地点
1
主要终点
Number of participants 1-2 weeks of age who present with continuing ventriculomegaly after CSF diversion as assessed by the clinical MRI examination

研究概览

简要总结

The purpose of this study is to evaluate the safety and efficacy of ventricular microdosing of indocyanine green (ICG) in order to assess cerebrospinal fluid (CSF) ventricular dynamics and extracranial CSF outflow using fluorescent Cap-based Transcranial Optical Tomography (fCTOT) and Near-InfraRed Fluorescent (NIRF) imaging and to evaluate inflammation markers of the CSF and to correlate with CSF ventricular dynamics, extracranial outflow into the lymphatics, ventriculomegaly, and patient's clinical outcome in order to understand how inflammation may impact that status of extracranial outflow.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
— 至 6 Months(Child)
性别
All
接受健康志愿者

入选标准

  • Children born premature currently in the NICU with a diagnosis of PHH who have undergone ventricular reservoir placement.
  • For the first four study subjects, we will attempt for the child to undergo CT cisternography when clinically stable 3-4 weeks after reservoir placement.

排除标准

  • Parents who do not consent for procedure on their child
  • Children who are deemed clinically unstable or unsuitable for imaging by clinical staff as defined by the subject's level of intensive care (e.g. can the subject be repositioned without compromise to the level of care needed or condition)
  • Children known or suspected to have allergy to iodine or ICG
  • Children who do not have a subcutaneous reservoir for CSF diversion from the lateral ventricle

研究组 & 干预措施

fCTOT and NIRF imaging with ICG

Experimental

干预措施: fCTOT cap (Device)

fCTOT and NIRF imaging with ICG

Experimental

干预措施: NIRF planar imaging (Device)

fCTOT and NIRF imaging with ICG

Experimental

干预措施: ICG (Drug)

结局指标

主要结局

Number of participants 1-2 weeks of age who present with continuing ventriculomegaly after CSF diversion as assessed by the clinical MRI examination

时间窗: end of study (about 10 days form baseline)

Number of participants 1-2 months of age who present with elevated ventriculomegaly after Endoscopic Third Ventriculostomy (ETV)/Choroid Plexus Cauterization (CPC) as assessed by the clinical MRI examination

时间窗: end of study (about 10 days form baseline)

Number of participants 1-6 months of age who present with continuing ventriculomegaly after ETV/CPC as assessed by the clinical MRI examination

时间窗: end of study (about 10 days form baseline)

次要结局

  • Amount of pro-inflammatory cytokines measured in pg/ml(end of study (about 10 days form baseline))

研究者

发起方
Eva Sevick
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Eva Sevick

Professor

The University of Texas Health Science Center, Houston

研究点 (1)

Loading locations...

相似试验